Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$651M |
| 2 |
Monster Beverage
MNST
|
+$615M |
| 3 |
Intercontinental Exchange
ICE
|
+$556M |
| 4 |
Johnson & Johnson
JNJ
|
+$382M |
| 5 |
Applied Materials
AMAT
|
+$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$771M |
| 3 |
Deere & Co
DE
|
+$597M |
| 4 |
Meta Platforms (Facebook)
META
|
+$543M |
| 5 |
Microsoft
MSFT
|
+$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Idexx Laboratories
IDXX
$51B
| $5.98M | ﹤0.01% |
11,834
+53
| +0.4% | +$26.8K |
|
827
Dominion Energy
D
$50.7B
| $5.97M | ﹤0.01% |
103,376
| – | – |
|
828
Coherent
COHR
$16.1B
| $5.97M | ﹤0.01% |
67,186
-3,100
| -4% | -$275K |
|
829
Alarm.com
ALRM
$2.76B
| $5.94M | ﹤0.01% |
108,664
-18,747
| -15% | -$1.02M |
|
830
Infosys
INFY
$70.4B
| $5.91M | ﹤0.01% |
265,474
-2,068
| -0.8% | -$46K |
|
831
Jackson Financial
JXN
$6.75B
| $5.86M | ﹤0.01% |
64,219
+14,675
| +30% | +$1.34M |
|
|
ORKA
832
Oruka Therapeutics, Inc. Common Stock
ORKA
$591M
| $5.84M | ﹤0.01% |
236,116
+120,888
| +105% | +$2.99M |
|
833
Axalta
AXTA
$6.7B
| $5.81M | ﹤0.01% |
160,458
+35,496
| +28% | +$1.28M |
|
834
Keurig Dr Pepper
KDP
$37.3B
| $5.8M | ﹤0.01% |
154,780
-2,000
| -1% | -$74.9K |
|
835
CBIZ
CBZ
$3.01B
| $5.78M | ﹤0.01% |
85,964
+2,664
| +3% | +$179K |
|
836
Ventas
VTR
$31.5B
| $5.77M | ﹤0.01% |
90,037
| – | – |
|
837
Curtiss-Wright
CW
$18.7B
| $5.75M | ﹤0.01% |
17,491
| – | – |
|
838
XPO
XPO
$15.3B
| $5.75M | ﹤0.01% |
53,496
| – | – |
|
839
Agilent Technologies
A
$35.2B
| $5.75M | ﹤0.01% |
38,726
| – | – |
|
840
Performance Food Group
PFGC
$16.3B
| $5.74M | ﹤0.01% |
73,232
| – | – |
|
841
ePlus
PLUS
$1.93B
| $5.71M | ﹤0.01% |
58,015
+545
| +0.9% | +$53.6K |
|
842
CytomX Therapeutics
CTMX
$341M
| $5.7M | ﹤0.01% |
4,809,518
-1,492,465
| -24% | -$1.77M |
|
843
Qiagen
QGEN
$9.98B
| $5.7M | ﹤0.01% |
122,557
-296,224
| -71% | -$13.8M |
|
844
Consolidated Edison
ED
$35B
| $5.67M | ﹤0.01% |
54,440
+1,500
| +3% | +$156K |
|
845
MSCI
MSCI
$43.6B
| $5.62M | ﹤0.01% |
9,645
+194
| +2% | +$113K |
|
846
Taylor Morrison
TMHC
$6.89B
| $5.56M | ﹤0.01% |
79,201
+5,081
| +7% | +$357K |
|
847
Murphy USA
MUSA
$7.26B
| $5.56M | ﹤0.01% |
11,294
-198
| -2% | -$97.5K |
|
848
Monolithic Power Systems
MPWR
$41B
| $5.55M | ﹤0.01% |
5,996
+2,134
| +55% | +$1.97M |
|
849
WillScot Mobile Mini Holdings
WSC
$4.17B
| $5.54M | ﹤0.01% |
147,175
+6,262
| +4% | +$236K |
|
850
Exelon
EXC
$43.8B
| $5.52M | ﹤0.01% |
136,225
-15,500
| -10% | -$628K |
|